| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |